Open AccessHypothesis: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19
Author(s) -
James H. Diaz
Publication year - 2020
Publication title -
journal of travel medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.985
H-Index - 59
eISSN - 1708-8305
pISSN - 1195-1982
DOI - 10.1093/jtm/taaa041
Subject(s) - medicine , angiotensin receptor blockers , receptor , angiotensin converting enzyme , renin–angiotensin system , angiotensin converting enzyme 2 , covid-19 , pharmacology , enzyme , angiotensin ii , angiotensin receptor , disease , endocrinology , infectious disease (medical specialty) , biochemistry , blood pressure , biology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom